TQVAX | VIVIX | TQVAX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 26 years | - |
Gain YTD | 21.229 | 17.922 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 42.8M | 184B | 0% |
Annual Yield % from dividends | 0.39 | 2.37 | 16% |
Returns for 1 year | 23.51 | 25.54 | 92% |
Returns for 3 years | 19.25 | 21.57 | 89% |
Returns for 5 years | 48.07 | 50.79 | 95% |
Returns for 10 years | N/A | 110.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PICOX | 40.80 | -0.29 | -0.71% |
Putnam International Capital Opp R6 | |||
GHTRX | 12.58 | -0.10 | -0.79% |
Goldman Sachs International T/M Eq R6 | |||
KESGX | 16.47 | -0.17 | -1.02% |
Kennedy Capital ESG SMID Cap I | |||
JDMAX | 143.57 | -1.79 | -1.23% |
Janus Henderson Enterprise A | |||
ACAEX | 12.45 | -0.18 | -1.43% |
American Century International Gr G |